Related Experiment Video
Updated: Dec 28, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.6K
Emphasis Learning, Features Repetition in Width Instead of Length to Improve Classification Performance: Case
Hamid Akramifard1, MohammadAli Balafar1, SeyedNaser Razavi1
1. Faculty of Electrical and Computer Engineering, University of Tabriz, East Azerbaijan, Tabriz 51666-16471, Iran.
Sensors (Basel, Switzerland)
|February 14, 2020
Summary
This study introduces a novel feature replication method for Alzheimer's disease (AD) diagnosis. The approach achieves state-of-the-art accuracy in classifying AD and mild cognitive impairment (MCI) patients.
Area of Science:
- Neuroimaging and Computational Neuroscience
- Medical Informatics and Artificial Intelligence
Background:
- Computer-aided diagnosis for Alzheimer's disease (AD) has advanced significantly, often integrating features from MRI, PET, and CSF.
- Current high-performance classification models (>90% accuracy) face challenges in further performance improvement.
Purpose of the Study:
- To propose a novel methodology for enhancing Alzheimer's disease (AD) diagnosis classification accuracy.
- To introduce a unique approach based on feature space replication rather than traditional sample space methods.
Main Methods:
- Feature extraction using VBM-SPM and embedding via concatenation to create subject feature vectors.
- Dimensionality reduction using Principal Component Analysis (PCA) to form a compact feature space.
- A novel iterative replication process on selected feature components, evaluated by Support Vector Machine (SVM) classifiers until performance convergence.
Main Results:
- Achieved state-of-the-art classification accuracies: 98.81% for AD vs. normal control (NC), 81.61% for MCI vs. NC, and 81.40% for AD vs. MCI.
- The proposed feature replication method demonstrated superior performance compared to existing literature for AD diagnosis.
Conclusions:
- The novel feature space replication methodology offers a significant advancement in computer-aided diagnosis for Alzheimer's disease.
- This approach effectively identifies key features and optimizes classification models for distinguishing between normal controls, MCI, and AD patients.
Related Concept Videos
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Alzheimer's Disease: Treatment
699
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
699

